Nifty
Sensex
:
:
11709.10
38969.80
-119.15 (-1.01%)
-382.87 (-0.97%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 533157 | NSE: SYNCOM

1.40
0.05 (3.70%)
21-May-2019 | 3:42PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  1.40
  •  1.40
  •  1.35
  •  1.35
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1863
  •  0.03
  •  5.40
  •  1.30

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 5.80
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 30.15
  • N/A
  • 0.72

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 25.00%
  • 3.68%
  • 65.77%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 5.55%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -3.70
  • -8.17
  • -12.93

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 12.35
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 70.26
  • 164.77

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.50
  • 0.65
  • 0.97

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -6.83
  • -28.67
  • -89.63

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
-
41.53
55.16
123.90
191.17
191.58
204.33
134.93
Net Sales Growth
-
-24.71%
-55.48%
-35.19%
-0.21%
-6.24%
51.43%
 
Cost Of Goods Sold
-
24.19
37.67
89.17
158.88
158.38
170.49
99.32
Gross Profit
-
17.33
17.48
34.73
32.29
33.20
33.84
35.62
GP Margin
-
41.73%
31.69%
28.03%
16.89%
17.33%
16.56%
26.40%
Total Expenditure
-
46.78
57.41
123.15
189.34
194.26
196.64
129.95
Power & Fuel Cost
-
1.28
1.59
1.71
1.53
1.76
1.37
1.17
% Of Sales
-
3.08%
2.88%
1.38%
0.80%
0.92%
0.67%
0.87%
Employee Cost
-
10.30
8.83
8.97
8.17
9.72
8.43
8.93
% Of Sales
-
24.80%
16.01%
7.24%
4.27%
5.07%
4.13%
6.62%
Manufacturing Exp.
-
3.42
2.36
14.00
8.56
14.15
8.77
10.44
% Of Sales
-
8.24%
4.28%
11.30%
4.48%
7.39%
4.29%
7.74%
General & Admin Exp.
-
3.33
3.70
4.60
5.47
4.95
6.17
4.44
% Of Sales
-
8.02%
6.71%
3.71%
2.86%
2.58%
3.02%
3.29%
Selling & Distn. Exp.
-
2.30
2.14
4.71
6.22
4.81
1.40
5.65
% Of Sales
-
5.54%
3.88%
3.80%
3.25%
2.51%
0.69%
4.19%
Miscellaneous Exp.
-
1.96
1.11
0.00
0.52
0.49
0.00
0.00
% Of Sales
-
4.72%
2.01%
0%
0.27%
0.26%
0%
0%
EBITDA
-
-5.25
-2.25
0.75
1.83
-2.68
7.69
4.98
EBITDA Margin
-
-12.64%
-4.08%
0.61%
0.96%
-1.40%
3.76%
3.69%
Other Income
-
0.44
2.28
2.98
2.77
3.07
2.26
4.04
Interest
-
0.28
3.10
3.32
4.57
4.19
3.68
2.50
Depreciation
-
3.74
4.61
4.64
5.35
3.77
2.29
2.32
PBT
-
-8.83
-7.67
-4.23
-5.32
-7.57
3.99
4.20
Tax
-
0.00
7.91
-0.80
-1.53
-3.21
-0.02
0.86
Tax Rate
-
0.00%
-7.96%
18.91%
28.76%
42.40%
-0.50%
20.48%
PAT
-
-78.24
-107.32
-3.43
-3.79
-4.36
4.01
3.35
PAT before Minority Interest
-
-78.24
-107.32
-3.43
-3.79
-4.36
4.01
3.35
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
-188.39%
-194.56%
-2.77%
-1.98%
-2.28%
1.96%
2.48%
PAT Growth
-
-
-
-
-
-
19.70%
 
Unadjusted EPS
-
-19.55
-26.85
-1.00
-0.95
-1.09
0.04
0.84

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
10.47
88.62
202.81
198.06
197.57
190.53
183.23
Share Capital
40.00
40.00
40.00
40.00
40.00
40.00
40.00
Total Reserves
-29.53
48.62
162.81
158.06
157.57
150.53
143.23
Non-Current Liabilities
5.20
8.62
4.04
6.88
6.59
10.14
6.44
Secured Loans
4.76
8.34
10.70
7.44
0.00
0.22
0.00
Unsecured Loans
0.00
0.00
0.00
5.43
11.27
11.39
7.85
Long Term Provisions
0.43
0.28
0.36
0.23
0.00
0.00
0.00
Current Liabilities
45.20
33.19
29.31
24.50
52.87
68.30
42.68
Trade Payables
21.34
13.07
7.44
6.22
18.97
43.59
26.50
Other Current Liabilities
9.39
4.26
2.02
2.92
7.95
4.42
0.81
Short Term Borrowings
13.24
14.49
19.26
14.72
24.62
19.07
14.33
Short Term Provisions
1.24
1.38
0.59
0.65
1.32
1.22
1.05
Total Liabilities
60.87
130.43
236.16
229.44
257.03
268.97
232.35
Net Block
16.48
20.08
20.70
23.47
28.19
25.66
16.05
Gross Block
24.10
23.97
46.84
45.70
45.36
39.12
27.25
Accumulated Depreciation
7.62
3.89
26.14
22.23
17.17
13.46
11.20
Non Current Assets
18.53
30.32
34.23
38.36
50.25
47.04
32.13
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
1.08
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
4.02
Long Term Loans & Adv.
2.05
10.23
13.53
14.89
22.06
21.38
10.97
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
42.34
100.12
200.95
189.59
204.80
221.94
200.22
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
9.53
10.80
13.35
13.31
12.21
19.49
66.51
Sundry Debtors
16.83
69.69
164.62
152.31
157.22
175.99
106.07
Cash & Bank
0.56
0.49
1.40
0.85
8.39
1.11
0.45
Other Current Assets
15.42
0.08
0.01
1.90
26.98
25.34
27.20
Short Term Loans & Adv.
15.40
19.05
21.56
21.21
25.44
24.77
26.37
Net Current Assets
-2.86
66.93
171.64
165.09
151.93
153.64
157.55
Total Assets
60.87
130.44
236.17
229.43
257.02
268.98
232.35

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
5.65
4.17
-7.98
-0.61
0.96
-1.18
-199.77
PBT
-78.24
-99.42
-4.23
-5.32
-4.36
4.01
3.34
Adjustment
73.18
97.57
7.05
8.88
5.26
5.90
5.39
Changes in Working Capital
10.71
6.91
-10.59
-3.89
0.06
-11.09
-208.50
Cash after chg. in Working capital
5.65
5.07
-7.78
-0.34
0.96
-1.18
-199.77
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.00
-0.90
-0.20
-0.27
0.00
0.00
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-0.97
4.86
9.38
5.93
5.06
-3.50
6.06
Net Fixed Assets
-0.13
22.87
-1.19
-0.34
-6.24
-10.78
Net Investments
36.32
54.49
0.00
0.00
0.00
-86.55
Others
-37.16
-72.50
10.57
6.27
11.30
93.83
Cash from Financing Activity
-4.85
-9.62
-0.93
-12.88
1.25
5.35
104.57
Net Cash Inflow / Outflow
-0.16
-0.59
0.47
-7.56
7.28
0.67
-89.13
Opening Cash & Equivalents
0.27
0.86
0.39
7.96
1.11
0.45
89.58
Closing Cash & Equivalent
0.11
0.27
0.86
0.39
8.39
1.11
0.45

Financial Ratios

Standalone /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
2.62
22.16
50.45
49.14
48.90
47.63
45.81
ROA
-81.79%
-58.55%
-1.47%
-1.56%
-1.66%
1.60%
1.44%
ROE
-157.91%
-73.90%
-1.72%
-1.93%
-2.26%
2.14%
1.83%
ROCE
-103.84%
-55.40%
-0.40%
-0.33%
-1.49%
3.59%
3.26%
Fixed Asset Turnover
1.74
1.57
2.68
4.20
4.54
6.16
4.95
Receivable days
377.37
768.13
466.84
295.49
317.41
251.92
286.93
Inventory Days
88.68
79.19
39.28
24.37
30.20
76.82
179.92
Payable days
142.69
64.41
20.21
24.23
59.93
90.63
52.94
Cash Conversion Cycle
323.37
782.90
485.91
295.63
287.68
238.11
413.91
Total Debt/Equity
2.38
0.29
0.15
0.14
0.19
0.16
0.12
Interest Cover
-277.82
-31.09
-0.28
-0.16
-0.81
2.08
2.68

Top Investors:

News Update:


  • Syncom Healthcare - Quarterly Results
    14th Feb 2019, 18:42 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.